+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Controlled-Release Drug Delivery Technology Market by Technology (Hydrogel, Ion Exchange, Matrix), Route Of Administration (Implantable, Nasal, Oral), Therapeutic Area, Drug Type, Formulation, End User - Global Forecast 2025-2030- Product Image
Controlled-Release Drug Delivery Technology Market by Technology (Hydrogel, Ion Exchange, Matrix), Route Of Administration (Implantable, Nasal, Oral), Therapeutic Area, Drug Type, Formulation, End User - Global Forecast 2025-2030- Product Image
Sale

Controlled-Release Drug Delivery Technology Market by Technology (Hydrogel, Ion Exchange, Matrix), Route Of Administration (Implantable, Nasal, Oral), Therapeutic Area, Drug Type, Formulation, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082145
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Controlled-release drug delivery technology is redefining how therapeutics are released, administered, and monitored across global healthcare systems. This market research report offers senior decision-makers an authoritative overview of current innovations, major challenges, and actionable trends shaping strategic investments in controlled-release platforms.

Market Snapshot: Controlled-Release Drug Delivery Technology

The controlled-release drug delivery market is characterized by significant advancements in material science and engineering, enabling targeted, sustained release across multiple drug types. Stakeholders benefit from increased patient compliance, reduced side effects, and adaptable dosing strategies. Growth is driven by demand for advanced therapeutics in areas such as central nervous system disorders, oncology, metabolic diseases, and pain management. Strong interest from biopharmaceutical firms, device manufacturers, and contract development and manufacturing organizations underscores robust competition. Regional dynamics are shaping adoption, with the Americas and Asia-Pacific leading innovation and local manufacturing capacity. Policy shifts and regulatory updates are fostering continued evolution and early product approvals for integrated solutions.

Scope & Segmentation of the Market

  • Technology Platforms: Hydrogel (pH-sensitive, temperature-sensitive), Ion Exchange (anionic, cationic), Matrix (natural polymer, synthetic polymer), Osmotic (elementary and push-pull pumps), Reservoir (encapsulated, film coating)
  • Routes of Administration: Implantable devices for contraceptive and intratumoral therapies; Nasal (drops, spray); Oral (capsule, tablet); Pulmonary (inhaler, nebulizer); Transdermal (patch)
  • Therapeutic Areas: Cardiovascular (hyperlipidemia, hypertension), Central Nervous System (epilepsy, Parkinson’s), Metabolic (diabetes, obesity), Oncology (breast, lung cancer), Pain Management (chronic, postoperative)
  • Drug Types: Biologic (monoclonal antibodies, recombinant proteins), Peptide, Small Molecule, Vaccine (inactivated, live attenuated)
  • Formulations: Implants (biodegradable, non-biodegradable), Microspheres (chitosan, PLGA), Patches (matrix, reservoir), Tablets (matrix, reservoir)
  • End Users: Homecare (infusion, self-administration), Hospitals & Clinics (ambulatory surgical centres, hospitals), Specialty Clinics (oncology, pain clinics)
  • Regional Coverage: Americas (United States—including California, Texas, New York, and more—Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (UK, Germany, UAE, South Africa, and others); Asia-Pacific (China, India, Japan, Australia, Korea, Southeast Asia)
  • Companies Analyzed: Johnson & Johnson, Novartis AG, Pfizer Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Abbott Laboratories, Takeda Pharmaceutical Company Limited, Baxter International Inc., AstraZeneca PLC

Key Takeaways: Strategic Insights for Decision-Makers

  • Controlled-release platforms advance personalized medicine by enabling site-specific, patient-tailored therapeutic regimens and integrated real-time monitoring solutions.
  • Emerging technologies—including stimuli-responsive hydrogels and multilayer reservoir coatings—are transforming product design, allowing for sustained drug levels and reduced dosing frequencies.
  • Collaborative models between pharmaceutical manufacturers, startups, and academic institutions are accelerating innovation, clinical development, and commercialization cycles.
  • Shifts in reimbursement policies and regulatory frameworks are catalyzing earlier engagement with health authorities and streamlining the approval of combination products.
  • Regional strategies must account for infrastructure maturity, local policy alignment, and the capacity for technology transfer to leverage unique opportunities in each geography.
  • Diversified portfolios integrating both biologics and small-molecule formulations are positioning companies for adaptive resilience and improved therapeutic outcomes.

Tariff Impact on Supply Chains and Market Operations

United States tariff measures introduced in 2025 have raised input costs for the controlled-release sector, especially for polymer excipients and precision components. Manufacturers are adapting by diversifying sourcing, exploring regional production hubs, and investing in automation to maintain cost efficiency and regulatory compliance. Stakeholders collaborate with policymakers to address downstream effects on patient access while safeguarding supply stability.

Methodology & Data Sources

This report is built on in-depth primary interviews with industry leaders, comprehensive analysis of clinical studies, patent reviews, and regulatory filings. Secondary sources include peer-reviewed publications and policy documents. Quantitative data were validated through cross-referencing manufacturing capacities, corporate announcements, and rigorous scenario analysis for both tariff impact and technology adoption.

Why This Report Matters for Senior Decision-Makers

  • Enables targeted investment decisions by mapping emerging controlled-release technologies and evolving patient-centric solutions across market segments.
  • Supports proactive risk management by clarifying tariff-driven cost pressures and supply chain diversification strategies.
  • Delivers strategic intelligence to drive partnerships, product pipeline development, and regulatory alignment in a highly competitive sector.

Conclusion

This strategic research arms leadership with the insights needed to navigate the evolving landscape of controlled-release drug delivery. Informed decision-making will unlock new opportunities and drive therapeutic innovation within dynamic global healthcare markets.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of stimuli-responsive polymers for targeted controlled drug release in oncology
5.2. Application of 3D printed micro-architectures for personalized sustained medication dosing
5.3. Adoption of biodegradable nanocarriers to improve bioavailability of hydrophobic drugs
5.4. Regulatory harmonization efforts driving global approval timelines for long acting injectables
5.5. Leverage of AI driven formulation optimization to accelerate controlled release platform development
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Controlled-Release Drug Delivery Technology Market, by Technology
8.1. Introduction
8.2. Hydrogel
8.2.1. pH-Sensitive
8.2.2. Temperature-Sensitive
8.3. Ion Exchange
8.3.1. Anionic
8.3.2. Cationic
8.4. Matrix
8.4.1. Natural Polymer
8.4.2. Synthetic Polymer
8.5. Osmotic
8.5.1. Elementary Osmotic Pump
8.5.2. Push-Pull Osmotic Pump
8.6. Reservoir
8.6.1. Encapsulated Reservoir
8.6.2. Film Coating
9. Controlled-Release Drug Delivery Technology Market, by Route Of Administration
9.1. Introduction
9.2. Implantable
9.2.1. Contraceptive
9.2.2. Intratumoral
9.3. Nasal
9.3.1. Drops
9.3.2. Spray
9.4. Oral
9.4.1. Capsule
9.4.2. Tablet
9.5. Pulmonary
9.5.1. Inhaler
9.5.2. Nebulizer
9.6. Transdermal
9.6.1. Patch
10. Controlled-Release Drug Delivery Technology Market, by Therapeutic Area
10.1. Introduction
10.2. Cardiovascular
10.2.1. Hyperlipidemia
10.2.2. Hypertension
10.3. CNS
10.3.1. Epilepsy
10.3.2. Parkinsons
10.4. Metabolic
10.4.1. Diabetes
10.4.2. Obesity
10.5. Oncology
10.5.1. Breast Cancer
10.5.2. Lung Cancer
10.6. Pain Management
10.6.1. Chronic Pain
10.6.2. Postoperative Pain
11. Controlled-Release Drug Delivery Technology Market, by Drug Type
11.1. Introduction
11.2. Biologic
11.2.1. Monoclonal Antibody
11.2.2. Recombinant Protein
11.3. Peptide
11.4. Small Molecule
11.5. Vaccine
11.5.1. Inactivated
11.5.2. Live Attenuated
12. Controlled-Release Drug Delivery Technology Market, by Formulation
12.1. Introduction
12.2. Implant
12.2.1. Biodegradable
12.2.2. Non-Biodegradable
12.3. Microsphere
12.3.1. Chitosan
12.3.2. PLGA
12.4. Patch
12.4.1. Matrix Patch
12.4.2. Reservoir Patch
12.5. Tablet
12.5.1. Matrix Tablet
12.5.2. Reservoir Tablet
13. Controlled-Release Drug Delivery Technology Market, by End User
13.1. Introduction
13.2. Homecare
13.2.1. Home Infusion
13.2.2. Self-Administration
13.3. Hospitals & Clinics
13.3.1. Ambulatory Surgical Centres
13.3.2. Hospitals
13.4. Specialty Clinics
13.4.1. Oncology Clinics
13.4.2. Pain Clinics
14. Americas Controlled-Release Drug Delivery Technology Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Controlled-Release Drug Delivery Technology Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Controlled-Release Drug Delivery Technology Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Johnson & Johnson
17.3.2. Novartis AG
17.3.3. Pfizer Inc.
17.3.4. Sanofi S.A.
17.3.5. Teva Pharmaceutical Industries Ltd.
17.3.6. Merck & Co., Inc.
17.3.7. Abbott Laboratories
17.3.8. Takeda Pharmaceutical Company Limited
17.3.9. Baxter International Inc.
17.3.10. AstraZeneca PLC
18. Research AI19. Research Statistics20. Research Contacts21. Research Articles22. Appendix
List of Figures
FIGURE 1. CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET: RESEARCHAI
FIGURE 28. CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET: RESEARCHSTATISTICS
FIGURE 29. CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET: RESEARCHCONTACTS
FIGURE 30. CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HYDROGEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HYDROGEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PH-SENSITIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PH-SENSITIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TEMPERATURE-SENSITIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TEMPERATURE-SENSITIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HYDROGEL, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HYDROGEL, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ION EXCHANGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ION EXCHANGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ANIONIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ANIONIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CATIONIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CATIONIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ION EXCHANGE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ION EXCHANGE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MATRIX, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MATRIX, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY NATURAL POLYMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY NATURAL POLYMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYNTHETIC POLYMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYNTHETIC POLYMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MATRIX, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MATRIX, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY OSMOTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY OSMOTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ELEMENTARY OSMOTIC PUMP, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ELEMENTARY OSMOTIC PUMP, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PUSH-PULL OSMOTIC PUMP, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PUSH-PULL OSMOTIC PUMP, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY OSMOTIC, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY OSMOTIC, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY RESERVOIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY RESERVOIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ENCAPSULATED RESERVOIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ENCAPSULATED RESERVOIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FILM COATING, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FILM COATING, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY RESERVOIR, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY RESERVOIR, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY IMPLANTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY IMPLANTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTRACEPTIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTRACEPTIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY INTRATUMORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY INTRATUMORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY IMPLANTABLE, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY IMPLANTABLE, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY NASAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY NASAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DROPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DROPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SPRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SPRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY NASAL, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY NASAL, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PULMONARY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PULMONARY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY INHALER, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY INHALER, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY NEBULIZER, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PULMONARY, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PULMONARY, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TRANSDERMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PATCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PATCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TRANSDERMAL, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TRANSDERMAL, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HYPERLIPIDEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HYPERLIPIDEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HYPERTENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CNS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CNS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY EPILEPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PARKINSONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PARKINSONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CNS, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CNS, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY METABOLIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY METABOLIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DIABETES, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DIABETES, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY OBESITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY OBESITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY METABOLIC, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY METABOLIC, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY POSTOPERATIVE PAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY POSTOPERATIVE PAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY BIOLOGIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY BIOLOGIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY BIOLOGIC, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY BIOLOGIC, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PEPTIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PEPTIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY INACTIVATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 157. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY IMPLANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 158. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY IMPLANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 159. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY BIODEGRADABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 160. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY BIODEGRADABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 161. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY NON-BIODEGRADABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 162. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY NON-BIODEGRADABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 163. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY IMPLANT, 2018-2024 (USD MILLION)
TABLE 164. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY IMPLANT, 2025-2030 (USD MILLION)
TABLE 165. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MICROSPHERE, BY REGION, 2018-2024 (USD MILLION)
TABLE 166. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MICROSPHERE, BY REGION, 2025-2030 (USD MILLION)
TABLE 167. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CHITOSAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 168. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CHITOSAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 169. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PLGA, BY REGION, 2018-2024 (USD MILLION)
TABLE 170. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PLGA, BY REGION, 2025-2030 (USD MILLION)
TABLE 171. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MICROSPHERE, 2018-2024 (USD MILLION)
TABLE 172. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MICROSPHERE, 2025-2030 (USD MILLION)
TABLE 173. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PATCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 174. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PATCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 175. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MATRIX PATCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 176. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MATRIX PATCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 177. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY RESERVOIR PATCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 178. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY RESERVOIR PATCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 179. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PATCH, 2018-2024 (USD MILLION)
TABLE 180. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PATCH, 2025-2030 (USD MILLION)
TABLE 181. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 182. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 183. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MATRIX TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 184. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MATRIX TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 185. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY RESERVOIR TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 186. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY RESERVOIR TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 187. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 188. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 189. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOMECARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 192. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOMECARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 193. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOME INFUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 194. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOME INFUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 195. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SELF-ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 196. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SELF-ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 197. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 198. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 199. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 200. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 201. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY REGION, 2018-2024 (USD MILLION)
TABLE 202. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY REGION, 2025-2030 (USD MILLION)
TABLE 203. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 204. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 205. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 206. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 207. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 208. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 209. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 210. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 211. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PAIN CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 212. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PAIN CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 213. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 214. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 215. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 216. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 217. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HYDROGEL, 2018-2024 (USD MILLION)
TABLE 218. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HYDROGEL, 2025-2030 (USD MILLION)
TABLE 219. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ION EXCHANGE, 2018-2024 (USD MILLION)
TABLE 220. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ION EXCHANGE, 2025-2030 (USD MILLION)
TABLE 221. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MATRIX, 2018-2024 (USD MILLION)
TABLE 222. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MATRIX, 2025-2030 (USD MILLION)
TABLE 223. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY OSMOTIC, 2018-2024 (USD MILLION)
TABLE 224. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY OSMOTIC, 2025-2030 (USD MILLION)
TABLE 225. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY RESERVOIR, 2018-2024 (USD MILLION)
TABLE 226. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY RESERVOIR, 2025-2030 (USD MILLION)
TABLE 227. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 228. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 229. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY IMPLANTABLE, 2018-2024 (USD MILLION)
TABLE 230. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY IMPLANTABLE, 2025-2030 (USD MILLION)
TABLE 231. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY NASAL, 2018-2024 (USD MILLION)
TABLE 232. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY NASAL, 2025-2030 (USD MILLION)
TABLE 233. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 234. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 235. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PULMONARY, 2018-2024 (USD MILLION)
TABLE 236. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PULMONARY, 2025-2030 (USD MILLION)
TABLE 237. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TRANSDERMAL, 2018-2024 (USD MILLION)
TABLE 238. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TRANSDERMAL, 2025-2030 (USD MILLION)
TABLE 239. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 240. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 241. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 242. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 243. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CNS, 2018-2024 (USD MILLION)
TABLE 244. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CNS, 2025-2030 (USD MILLION)
TABLE 245. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY METABOLIC, 2018-2024 (USD MILLION)
TABLE 246. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY METABOLIC, 2025-2030 (USD MILLION)
TABLE 247. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 248. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 249. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 250. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 251. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 252. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 253. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY BIOLOGIC, 2018-2024 (USD MILLION)
TABLE 254. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY BIOLOGIC, 2025-2030 (USD MILLION)
TABLE 255. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 256. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 257. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 258. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 259. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY IMPLANT, 2018-2024 (USD MILLION)
TABLE 260. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY IMPLANT, 2025-2030 (USD MILLION)
TABLE 261. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MICROSPHERE, 2018-2024 (USD MILLION)
TABLE 262. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MICROSPHERE, 2025-2030 (USD MILLION)
TABLE 263. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PATCH, 2018-2024 (USD MILLION)
TABLE 264. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PATCH, 2025-2030 (USD MILLION)
TABLE 265. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 266. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 267. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 270. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 271. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 272. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 273. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SPEC

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Controlled-Release Drug Delivery Technology market report include:
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Merck & Co., Inc.
  • Abbott Laboratories
  • Takeda Pharmaceutical Company Limited
  • Baxter International Inc.
  • AstraZeneca PLC

Related Topics

Related Reports

Drug & Gene Delivery Devices Market by Technology (Hydrogel Based, Liposomal, Nanoparticle), Device Type (Auto Injector, Infusion Pump, Needle Free Injector), Molecule Type, End User, Application, Therapeutic Area - Global Forecast 2025-2030 - Product Image

Drug & Gene Delivery Devices Market by Technology (Hydrogel Based, Liposomal, Nanoparticle), Device Type (Auto Injector, Infusion Pump, Needle Free Injector), Molecule Type, End User, Application, Therapeutic Area - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Novel Drug Delivery Systems Market by Route Of Administration (Inhalation, Injectable, Nasal), Technology (Hydrogels, Implants, Microneedles), Application, Product Type, End User - Global Forecast 2025-2030 - Product Image

Novel Drug Delivery Systems Market by Route Of Administration (Inhalation, Injectable, Nasal), Technology (Hydrogels, Implants, Microneedles), Application, Product Type, End User - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Hydrogels in Drug Delivery. Advances in the Manufacture, Characterization, and Application of Hydrogels to Address Current Global Healthcare Challenges - Product Image

Hydrogels in Drug Delivery. Advances in the Manufacture, Characterization, and Application of Hydrogels to Address Current Global Healthcare Challenges

  • Book
  • Global
Hydrogel-based Drug Delivery Systems - Global Strategic Business Report - Product Image

Hydrogel-based Drug Delivery Systems - Global Strategic Business Report

  • Report
  • 290 Pages
  • Global
From
Controlled Release Drug Delivery - Global Strategic Business Report - Product Image

Controlled Release Drug Delivery - Global Strategic Business Report

  • Report
  • 294 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.